Skip to main content
. 2020 Oct 14;11(12):2374–2381. doi: 10.1021/acsmedchemlett.0c00255

Figure 4.

Figure 4

In vivo PK/PD of 24 showing (a) pIRAK1 modulation and (b) plasma–tumor exposures. Mean mPPB of 24 = 92.8% (Average of 2 determinations). Unbound plasma exposures at 12 and 24 h estimated to be 868.0 and 49.3 ng/mL, respectively.